GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (FRA:04K) » Definitions » FCF Yield %

Knight Therapeutics (FRA:04K) FCF Yield % : 7.97 (As of May. 19, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Knight Therapeutics's Trailing 12-Month Free Cash Flow is €33.8 Mil, and Market Cap is €418.6 Mil. Therefore, Knight Therapeutics's FCF Yield % for today is 7.97%.

The historical rank and industry rank for Knight Therapeutics's FCF Yield % or its related term are showing as below:

FRA:04K' s FCF Yield % Range Over the Past 10 Years
Min: -30.9   Med: 0.49   Max: 9
Current: 7.97


During the past 11 years, the highest FCF Yield % of Knight Therapeutics was 9.00%. The lowest was -30.90%. And the median was 0.49%.

FRA:04K's FCF Yield % is ranked better than
87.07% of 1083 companies
in the Drug Manufacturers industry
Industry Median: -0.49 vs FRA:04K: 7.97

Knight Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 22.97%.


Knight Therapeutics FCF Yield % Historical Data

The historical data trend for Knight Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics FCF Yield % Chart

Knight Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 -4.92 -29.28 3.26 4.99

Knight Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.87 -1.29 12.66 12.45 14.44

Competitive Comparison of Knight Therapeutics's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Knight Therapeutics's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Knight Therapeutics's FCF Yield % falls into.



Knight Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Knight Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=17.759 / 356.1184
=4.99%

Knight Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=13.519 * 4 / 374.3919
=14.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Knight Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Knight Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Knight Therapeutics (FRA:04K) Business Description

Traded in Other Exchanges
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Knight Therapeutics (FRA:04K) Headlines

No Headlines